We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pocket Colposcope Promises Easier Cancer Screening

By HospiMedica International staff writers
Posted on 30 Jun 2017
A novel handheld device could replace uncomfortable speculums and high-cost colposcopes used for cervical cancer screening.

Developed by researchers at Duke University (Durham NC, USA), the POCkeT colposcope is a miniature, tampon-sized vaginal inserter with a slim tubular body that has a funnel-like curved tip measuring approximately 2.5 cm in diameter. More...
The inserter has a channel through which a two megapixel mini camera with light emitting diode (LED) illumination fits in in order to capture an image. The device also includes a channel through which contrast agents, such as acetic acid or Lugol’s iodine, can be used so that cervical cancer screening procedures can be applied.

The POCkeT colposcope, which was developed using 3D computer-aided design (CAD) software, was tested using mechanical simulations on a custom vaginal phantom model, employing a range of vaginal pressures and uterine tilts in order to finalize the optimal design. Two final designs were tested with fifteen volunteers to assess cervix visualization, comfort, and usability, as compared to a standard metal speculum. The POCkeT colposcope can also connect to other devices, including laptops or cell phones. The study describing the design process and testing were published on May 31, 2017, in PLOS One.

“The mortality rate of cervical cancer should absolutely be zero percent because we have all the tools to see and treat it; but it isn’t,” said senior author professor of biomedical engineering Nimmi Ramanujam, PhD. “That is in part because women do not receive screening or do not follow up on a positive screening to have colposcopy performed at a referral clinic. We need to bring colposcopy to women so that we can reduce this complicated string of actions into a single touch point.”

Cervical cancer is the fourth most common cancer in women, with more than 500,000 new cases occurring annually worldwide. The two most common detection methods include the Pap smear, which can be performed by a non-specialist, and colposcopy, which requires visualization of the cervix using a speculum, a colposcope, and a trained professional to administer the test. Colposcopes and people who know how to use them are difficult to find in many low-income regions.

Related Links:
Duke University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.